New Development and evaluation of new assays and test methods. Investigating AGO2, a Key Enzyme in the miRNA Pathway, as a Non-Invasive Diagnostic Biomarker for Solid Tumours and Evaluating the Potential of a Combined Panel with Conventional Tumour Markers for Improved Cancer Detection and Tumour Origin Identification.
Project Member(s): Hutvagner, G.
Funding or Partner Organisation: AUSTRALIAN INSTITUTE OF MEDICAL AND CLINICAL SCIENTISTS (AIMS Doctor of Philosophy (PhD) Research Seeding Grant)
AUSTRALIAN INSTITUTE OF MEDICAL AND CLINICAL SCIENTISTS (AIMS Doctor of Philosophy (PhD) Research Seeding Grant)
Start year: 2023
Summary: To test a newly discovered biomarkers in liquid biopsies
FOR Codes: Medical biochemistry and metabolomics, Medical biotechnology, Clinical health